Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France

Trial Profile

Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2015

At a glance

  • Drugs Quetiapine (Primary) ; Antidepressants; Antipsychotics; Lamotrigine; Lithium; Valproic acid
  • Indications Bipolar disorders; Schizophrenia
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 29 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Feb 2014 According to ClinicalTrials.gov record trial status changed from recruiting to active, no longer recruiting.
    • 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top